Tag: Dr Evan S Dellon

Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and...

Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older